Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients

NCT01491295 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

160

Enrollment

OTHER_GOV

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: Tenofovir disoproxil fumarate
DRUG: Lamivudine plus adefovir

Sponsor

Taipei Veterans General Hospital, Taiwan

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]